Skip to main content
Clinical Trials/NCT06674551
NCT06674551
Not yet recruiting
Not Applicable

Comparative Study Between Combined Suprascapular and Axillary Nerve Blocks Versus Interscalene Nerve Block Regarding Phrenic Nerve Affection Assessed by Ultrasound Guided Diaphragmatic Excursion in Shoulder Arthroscopy Surgeries

Ain Shams University0 sites60 target enrollmentNovember 20, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Interscalene Nerve Block
Sponsor
Ain Shams University
Enrollment
60
Primary Endpoint
incidence of hemidiaphragmatic paralysis measured by ultrasound.
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

This study is aims to compare between combined suprascapular and axillary nerve blocks versus interscalene nerve block regarding phrenic nerve affection assessed by ultrasound guided diaphragmatic excursion in shoulder arthroscopy surgeries.

Detailed Description

Interscalene approach of brachial plexus nerve block is recognized as the gold standard technique for postoperative pain control after shoulder arthroscopy surgeries . However, it is associated with major adverse effects and possibly critical complications including phrenic nerve affection. Combined suprascapular and axillary nerve blocks are considered to be a safe and effective alternative to interscalene nerve block for shoulder surgery. Futher studies had been done regarding postoperative analgesia after shoulder arthroscopy surgeries using intersalene nerve block versus suprascapular and axillary nerve blocks. In this study, we will Compare between combined suprascapular and axillary nerve blocks vs interscalene nerve block regarding objective phrenic nerve affection known as a serious complication of interscalene nerve block.

Registry
clinicaltrials.gov
Start Date
November 20, 2024
End Date
November 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 18 - 60 years old.
  • Both sexes.
  • ASA physical status classes I - II.
  • Body mass index: 18-35 kg/ m2.

Exclusion Criteria

  • Infection at site of injection.
  • Psychiatric illness.
  • Central Nervous System Diseases like (epilepsy, stroke ...etc.) or neurological disease affecting patient's upper limb.
  • Dependence on opiates and psycho-dynamic medications.
  • Moderate to severe pulmonary disease.
  • Coagulopathy and bleeding disorders.
  • Allergies to drug used (Bupivacaine 0.5%).
  • Previous surgery at site of injection and history of radiotherapy.

Outcomes

Primary Outcomes

incidence of hemidiaphragmatic paralysis measured by ultrasound.

Time Frame: measurement will be taken 8 hours after the performance of the block for fourth and last time.

defined as a ≥ 25% reduction in diaphragmatic excursion measured by ultrasound.

Secondary Outcomes

  • postoperative pain using NRS(24 hours postoperative)

Similar Trials